SfN 2006, Day 1

I flew in this morning and thought I would easily make it to Frank Gehry’s talk at noon, but this being my first time in Atlanta it took me a while to find my hotel, so I missed it. Bummer. Do write in and let me know what he spoke about. I assume he was less controversial than last year’s “Neuroscience and Society Dialogues” speaker 🙂

I poked my head into the symposium on the ongoing efforts to cure Parkinson’s with dopaminergic neurons derived from ES cells (progress is being made, though as usual the goal seems to recede as we approach it), and learned about synaptic scaling from Gina Turrigiano’s polished presentation. Michael Sendtner however made my day when he told me that Bavarian politicians were impressed by our recent editorial on a new competitive university funding scheme in Germany (in our June issue). Bavarian politicians are a notoriously crusty bunch, very hard to impress. This scary guy is the prototype of homo politicus bavariensis – the Munich airport is named after him…

See you in Atlanta?

The big SfN neuroscience bash is coming up fast, starting this Saturday. We are sending quite a big delegation, including our chief editor Sandra Aamodt, my colleague Josh McDermott and myself, plus John Spiro and I-han Chou from Nature. You’ll have a chance to meet us at the Nature booth, #1832 in the Exhibitors’ Hall, where we’ll be holding court (ahem…) for about an hour each. Tentatively, you can shake hands with Sandra on Sunday afternoon from 3:30 to 4:30, and yell at me on Monday from 2 to 3 p.m. Times may change. Current info and other editors’ booth hours will be posted on a chalkboard at the booth. Our marketing colleagues tell me they’ll distribute free journal copies and other goodies at the booth, and they’ve also put up a special SfN 2006 webpage to give you easy access to the most recent neuroscience coverage by Nature Publishing.

This blog should see some real action as my colleagues have solemnly promised to post their impressions daily! So check back often. If you think I should come by your poster or slide talk, please post a comment with your abstract and abstract number. I look forward to meeting y’all (and to hearing those wonderful Southern accents again!)

Sunday’s new NN papers

Nozaki et al., Limited transfer of learning between unimanual and bimanual skills within the same limb

Schenk, An allocentric rather than perceptual deficit in patient D.F.

Amitay et al., Discrimination learning induced by training with identical stimuli

Hafed & Krauzlis, Ongoing eye movements constrain visual perception

Pasalar et al., Force field effects on cerebellar Purkinje cell discharge with implications for internal models

Enjoy.

Peer review in the New York Times, again

You might be interested in this Associated Press piece on the NYT website, on new web-based ‘open peer review’ journals . The article is apparently motivated by the imminent launch of PloS ONE. However, this blog and our colleagues at Free Association also get a brief mention at the very end of the piece, as “blog-like forums for researchers to post their thoughts on published articles.”

Well, to make it easier for y’all to post your thoughts, I have just fixed all the newly obsolete links to our October issue papers. Comment away…

Addendum to ‘wanderings’

I can’t tear myself away from that story on awakening PVS patients with a sleeping pill… Before I finally pack my bags for the night let me direct you to https://blog.bioethics.net/. These guys blogged about that story back in May, when it was really news. They are getting it wrong when calling PVS patients “people who are basically dead” (a weird mistake for professional bioethicists to make!), but their piece together with the comments it elicited is still worth reading. Certainly the short paper in Neurorehabilitation needs to be followed up with a large-scale study.

Online wanderings dig up some amazing news

(This is a peripatetic blog entry, but bear with me. It gets neuroscientific eventually!)

“Eeek – it’s Friday afternoon, and I haven’t managed to put up a real blog entry yet this week!” Thus I dug myself out of the manuscript pile and thought about typing up something about Nature’s open peer review trial. I had posted the links a couple of weeks ago, and last week I noticed they weren’t working anymore, so maybe that experiment had now ended (it was supposed to run for three months starting in mid-June), and maybe, just maybe, the Nature folks had already posted some evaluation or conclusions. However, those links work tonight, and manuscripts are still up for commenting, so obviously it isn’t over yet.

I clicked over to Timo Hannay’s Nascent blog (always good for cutting edge news about my employers!) to see whether he had anything enlightening to say about the open peer review trial. He hadn’t really (apart from this entry, blasting The Wall Street Journal and other outlets for having noticed the experiment only after more than two months, and getting it wrong, too…) Rummaging further around Nascent, I came across a link to ContentWise. ContentWise, as far as I can tell, is a blog by two publishing consultants who, again as far as I can tell, have no direct connection to Nature Publishing Group. But they are praising Nature.com as a transcendent website. TRANSCENDENT? Just what have these guys been smoking???

Now, I use Nature.com in the daily grind, so I might well be overlooking the diamond right under my nose. What exactly do ContentWise find so transcendent — I just can’t get over that word, folks! — about Nature.com? Turns out they praise the various interactive web initiatives, Connotea, the Nature Protocols Network, and Dissect Medicine, an example of a “niche-specific article recommendations network.”

Uh-huh. I work for this company and I have never heard so much as a whisper about Dissect Medicine.

So over I click to DM, and do some more rummaging. And there, finally, I find some neuroscience usable as blog fodder! Seems the idea behind DM is that users/readers are invited to post links to medicine-related news articles, and users can then vote for what they think are the most interesting articles, and those then rise to the top of the list, becoming literally “headlines.”

(Somebody who knows anything about DM please correct me if I’ve got this all wrong.)

Astonishingly this recent story from The Guardian is not at the top. It reports that seven years ago a physician in South Africa discovered by pure serendipity that the drug zolpidem could wake up patients who’ve suffered in persistent vegetative states (PVS) for years. Zolpidem is sold as “Ambien” in my part of the world — a common sleeping pill. These PVS patients are given an Ambien in the morning, and can function and communicate for several hours. Apparently it works day after day. The scientific report of these cases is here.

I am just floored at this fabulous news, and amazed that it has been so little publicized. (Maybe I am just sleepwalking…) The story is eerily reminiscent of Oliver Sacks’ “Awakenings”. I have no idea on what percentage of PVS patients this trick would work (and of course each patient is a unique case with unique lesions), nor does anyone understand how it works, but nevertheless. Anything that can help severely brain-damaged people is good news (unless it’s a hoax – I hope not!!)

In the hopeful vein, DM also gave me this story about an antiinflammatory medication reversing liver cirrhosis, from the BBC. Not neuroscience, you say? Maybe, but liver cirrhosis is almost always caused by chronic alcohol abuse, and alcoholism like all addictions is to a large extent a malfunction of the brain. We deal with plenty of papers on addiction mechanisms at Nature Neuroscience! And on the blog we consider anything with even a tenuous link to neuroscience fair game.

Great stories indeed are listed in DM, but the top headline tonight is “Madrid Fashion Show Bans 5 Thin Models” !!

Somebody explain this to me, please.

And let’s put an end to this embarrassment by casting our votes on Dissect Medicine for the Guardian story, “The ‘miracle’ treatment that’s bringing the brain-damaged back to life”.

New NN papers currently online

All these papers will be printed in our upcoming October issue.

Published online September 17:

Smith et al., Kinase activity of mutant LRRK2 mediates neuronal toxicity

Williams et al., Local caspase activity directs engulfment of dendrites during pruning

Kim et al., NGL family PSD-95–interacting adhesion molecules regulate excitatory synapse formation

Leung et al., Asymmetrical -actin mRNA translation in growth cones mediates attractive turning to netrin-1

Yao et al., An essential role for -actin mRNA localization and translation in Ca2+-dependent growth cone guidance

Wang et al., Functional alignment of feedback effects from visual cortex to thalamus

Published online September 10:

Cano et al., Brain state and contrast sensitivity in the awake visual thalamus

Ling & Carrasco, When sustained attention impairs perception

Borrell & Marin, Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling

Farrow et al., Nonlinear, binocular interactions underlying flow field selectivity of a motion-sensitive neuron

Paz et al., Emotional enhancement of memory via amygdala-driven facilitation of rhinal interactions

Wu et al., Soluble adenylyl cyclase is required for netrin-1 signaling in nerve growth cones

Published online September 3:

Robles & Gomez, Focal adhesion kinase signaling at sites of integrin-mediated adhesion controls axon pathfinding

Published online August 27:

Custer et al., Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport

Next, I’ll be putting up the links to the papers we published over the summer. These will be posted with fake dates to fit their publication months, so readers of the blog will have an easier time finding them. Thanks for your understanding.